Nearly 200 million individuals worldwide are currently infected with hepatitis C virus (HCV)
1 . Combination therapy with pegylated interferon and ribavirin, the latest treatment for HCV …

We present a model of HIV dynamics under antiretroviral therapy that combines drug
pharmacokinetics and intracellular delay. A two compartment pharmacokinetic model is employed …

The entry of SARS-CoV-2 into target cells requires the activation of its surface spike protein,
S, by host proteases. The host serine protease TMPRSS2 and cysteine proteases Cathepsin …

Predicting the efficacy of COVID-19 vaccines would aid vaccine development and usage
strategies, which is of importance given their limited supplies. Here we develop a multiscale …

The high incidence of multiple infections of cells by HIV sets the stage for rapid HIV evolution
by means of recombination. Yet how HIV dynamics proceeds with multiple infections …

We analyse viral load data of five patients under ritonavir monotherapy using a model of
HIV dynamics under antiretroviral therapy that includes both drug pharmacokinetics and the …

The recent application of two-photon microscopy to the visualization of T cell movement has
presented trajectories of individual T cells within lymphoid organs both in the presence and …

Human immunodeficiency virus type 1 (HIV-1)-infected splenocytes in humans were recently
shown to harbor three to four proviruses per cell on average (A. Jung et al., Nature 418:144…

The efficacy of COVID-19 vaccines appears to depend in complex ways on the vaccine
dosage and the interval between the prime and boost doses. Unexpectedly, lower dose prime …

SARS-CoV-2 infection results in highly heterogeneous outcomes, from cure without symptoms
to acute respiratory distress and death. Empirical evidence points to the prominent roles …